February 2024

Phage Therapy in Livestock and Companion Animals家畜和伴侣动物中的噬菌体治疗

The irrational use of antibiotics has led to a high emergence of multi-drug resistant (MDR) bacteria. The traditional overuse of antibiotics in the animal feed industry plays a crucial role in the emergence of these pathogens that pose both economic and health problems. In addition, antibiotics have also recently experienced an increase to treat companion animal infections, promoting the emergence of MDR bacteria in pets, which can reach humans. Phages have been proposed as an alternative for antibiotics for the treatment of livestock and companion animal infections due to their multiple advantages as adaptative drugs, such as their ability to evolve, to multiply at the site of infections, and their high specificity. Moreover, phage-derived enzymes may also be an interesting approach. However, the lack of regulation for this type of pharmaceutical hinders its potential commercialization. In this review, we summarize the main recent studies on phage therapy in livestock and companion animals, providing an insight into current advances in this area and the future of treatments for bacterial infections.
抗生素的不合理使用导致了多重耐药菌的大量出现。在动物饲料工业中,抗生素的传统过度使用在这些病原体的出现中起着至关重要的作用,这些病原体造成了经济和健康问题。此外,抗生素最近也经历了治疗伴侣动物感染的增加,促进了宠物中MDR细菌的出现,这些细菌可以到达人类。由于噬菌体作为适应性药物的多种优势,例如它们在感染部位进化、繁殖的能力以及它们的高特异性,噬菌体已被提议作为抗生素的替代物用于治疗家畜和伴侣动物感染。此外,噬菌体衍生的酶也可能是一种有趣的方法。然而,缺乏对这类药物的监管阻碍了其潜在的商业化。 在这篇综述中,我们总结了最近在家畜和伴侣动物中的噬菌体治疗的主要研究,提供了对该领域当前进展和细菌感染治疗未来的见解。

Phage Therapy in Livestock and Companion Animals家畜和伴侣动物中的噬菌体治疗 Read More »

New Line 2023 Pathogen Detection and Bacteriophage Treatment Report: Sample Analysis and Results

In 2023, a total of 16,890 market samples were received by the R&D center. The collected samples were categorized based on different animal sources, with chicken source samples having the highest collection rate. When analyzed by region, samples from the Northeast region had the highest quantity. In total, 6,189 strains were isolated from the collected samples, among which E.

New Line 2023 Pathogen Detection and Bacteriophage Treatment Report: Sample Analysis and Results Read More »

山东新航线2023年度病原检测情况报告

Discover the findings of the 2023 Research and Development Center study, which collected 16,890 market samples. Learn about the distribution of samples by animal source and region, as well as the prevalence of pathogenic bacteria and antimicrobial resistance. Explore the use of bacteriophages as a solution to antibiotic resistance in the livestock industry. Find out more about Shandong New Line Biotechnology Co., Ltd., a leading company in bacteriophage research and development. #research #antimicrobialresistance

山东新航线2023年度病原检测情况报告 Read More »

New Line: Spearheading Phage-based Solutions for Resistant Bacterial Infections

Established in 2018, Shandong New Line Biotechnology is a renowned enterprise focused on research and development of alternative feed additive products. Join us in our mission to combat drug-resistant bacteria and revolutionize animal husbandry and agriculture.

New Line: Spearheading Phage-based Solutions for Resistant Bacterial Infections Read More »

Scroll to Top